4/12
02:03 am
agrx
Agile Therapeutics, Inc. (NASDAQ: AGRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
High
Report
Agile Therapeutics, Inc. (NASDAQ: AGRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/4
02:07 am
agrx
Agile Therapeutics, Inc. (NASDAQ: AGRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Agile Therapeutics, Inc. (NASDAQ: AGRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/1
05:31 pm
agrx
Agile Therapeutics, Inc. (NASDAQ:AGRX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Agile Therapeutics, Inc. (NASDAQ:AGRX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/28
08:05 am
agrx
Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update
Medium
Report
Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update
3/25
04:43 pm
agrx
Agile Therapeutics Announces Delisting from Nasdaq [Yahoo! Finance]
Low
Report
Agile Therapeutics Announces Delisting from Nasdaq [Yahoo! Finance]
3/25
04:30 pm
agrx
Agile Therapeutics Announces Delisting from Nasdaq
High
Report
Agile Therapeutics Announces Delisting from Nasdaq
3/21
06:35 am
agrx
Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024
Medium
Report
Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024
3/20
08:15 am
agrx
Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024
Medium
Report
Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024
3/19
11:11 pm
agrx
Agile Therapeutics, Inc. (NASDAQ: AGRX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Medium
Report
Agile Therapeutics, Inc. (NASDAQ: AGRX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
3/18
02:51 pm
agrx
Agile Therapeutics, Inc. (NASDAQ: AGRX) had its "hold" rating re-affirmed by analysts at Maxim Group.
Low
Report
Agile Therapeutics, Inc. (NASDAQ: AGRX) had its "hold" rating re-affirmed by analysts at Maxim Group.
3/13
07:31 am
agrx
Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution
Medium
Report
Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution
3/12
10:31 am
agrx
Global Contraceptive Drugs Market Size is Projected to Reach USD 28.96 billion by 2030, Growing at a CAGR of 7.3%: Straits Research [Yahoo! Finance]
Low
Report
Global Contraceptive Drugs Market Size is Projected to Reach USD 28.96 billion by 2030, Growing at a CAGR of 7.3%: Straits Research [Yahoo! Finance]
2/22
09:31 am
agrx
Thinking about buying stock in Agile Therapeutics, Nano-X Imaging, Eastside Distilling, Root Inc, or GigaCloud Technology?
High
Report
Thinking about buying stock in Agile Therapeutics, Nano-X Imaging, Eastside Distilling, Root Inc, or GigaCloud Technology?
2/22
09:15 am
agrx
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds [Yahoo! Finance]
High
Report
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds [Yahoo! Finance]
2/22
09:01 am
agrx
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
High
Report
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
2/15
04:41 pm
agrx
Agile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders' Equity Continued Listing Requirement & Provides Performance Update [Yahoo! Finance]
Medium
Report
Agile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders' Equity Continued Listing Requirement & Provides Performance Update [Yahoo! Finance]
2/15
04:30 pm
agrx
Agile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement & Provides Performance Update
Medium
Report
Agile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement & Provides Performance Update
1/23
09:29 am
agrx
The Biden-Harris Administration Announces New Guidance to Enable Expanded Access to All FDA-Approved Contraceptives Without Cost
Medium
Report
The Biden-Harris Administration Announces New Guidance to Enable Expanded Access to All FDA-Approved Contraceptives Without Cost
1/23
08:13 am
agrx
World Reproductive Health Devices Clinical Pipeline Research Report 2023: Stages of Development, Segments, Region and Countries, Regulatory Path and Competitive Landscape [Yahoo! Finance]
Medium
Report
World Reproductive Health Devices Clinical Pipeline Research Report 2023: Stages of Development, Segments, Region and Countries, Regulatory Path and Competitive Landscape [Yahoo! Finance]
1/22
05:07 pm
agrx
A Comprehensive Analysis of the Transdermal Drug Delivery Pipeline; Covering Development Stages, Regional Expansion, and Key Players: 2023 and Beyond [Yahoo! Finance]
Medium
Report
A Comprehensive Analysis of the Transdermal Drug Delivery Pipeline; Covering Development Stages, Regional Expansion, and Key Players: 2023 and Beyond [Yahoo! Finance]